New award for nicotine 24HRS patches with exelan pharmaceuticals, INC. Period of performance is 2/1/2026 - 1/31/2027.

Active Indefinite Delivery Contract Awarded Last action

Contract number
36E79726D0003
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 71% complete
IDV ceiling
$29,942,817.95
Award type
Single award
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite-delivery contract to Exelan Pharmaceuticals Inc. for nicotine 24-hour transdermal patches with a ceiling of $29,942,817.95, effective February 1, 2026.

The contract carries no set-aside designation and is unrestricted, fully open competitive. Place of performance is Exelan's primary manufacturing and distribution facility in Boca Raton, Florida, with secondary locations in Cary, North Carolina; Summit, New Jersey; Ottawa, Ontario, Canada; and other designated federal delivery locations as specified by contracting agencies.

The originating solicitation (RFP 36E79725R0050, posted June 26, 2025, with response deadline July 24, 2025) sought an uninterrupted source of supply for nicotine patches in three strengths—7 mg, 14 mg, and 21 mg—packaged in boxes of 14 patches each for distribution through the VA's Pharmaceutical Prime Vendor Programs to the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. Estimated annual requirements totaled 703,709 boxes across all three strengths.

The contract period runs from February 1, 2026, through January 31, 2027, and was structured as one base year plus four one-year option periods. The procurement falls under NAICS code 325412 (Pharmaceutical Preparation Manufacturing) and PSC code 6505 (Drugs and Biologicals). A modification incorporated Section 5 of Executive Order 14398 (Clause 52.222-90, addressing DEI discrimination by federal contractors) into the contract in April 2026.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00002 · Modification to incorporate section 5 of EO 14398, clause 52.222-90, addressing DEI discrimination by federal contractors (APR 2026), into the contract. $0
Add Subcontract Plan P00001 · This modification is issued to incorporate exelan's 2027 subcontracting plan effective for the period of april 1, 2026 - march 31, 2027. $0
Original award $0

Quick answers

Who was awarded contract 36E79726D0003?

36E79726D0003 was awarded to Exelan Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on February 1, 2026.

How much is contract 36E79726D0003 worth?

36E79726D0003's own ceiling is $29,942,818.

Who can order from contract 36E79726D0003?

36E79726D0003 is a single award indefinite delivery contract.

Was contract 36E79726D0003 competed?

The extent of competition for 36E79726D0003 was full and open competition. The government received 4 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV